CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jilin Provnc Hnn Chnglng Bio-pharm CoLtd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jilin Provnc Hnn Chnglng Bio-pharm CoLtd
No. 31 Beishan Street
Chaoyang Town, Huinan County
Phone: +86 4358218333p:+86 4358218333 TONGHUA, JLN  135100  China Ticker: 80498049
Business Summary
Jilin Province Huinan Changlong Bio-pharmacy Company Limited is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products. Its products are mainly sold under the brand names of Changlong and Qing Tong. Its primary products include tablets, capsules, bulk drug, membrane, pills, bulk drug, powder for injection, lyophilized powder for injection, small volume parenteral solutions, sterile bulk drug and solution. The Company is also engaged in the trading of biochemical medicine through its subsidiaries. Its principal subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited and Jilin Province Medicinal Plants Trading Company Limited.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Finance Officer, Executive Director Bao GangZhao 48 3/1/2007
Executive Chairman of the Board, CEO, Compliance Officer, General Manager, Secretary - Party Commit HongZhang 60 1/1/2010
Executive Director, Deputy General Manager Xiao GuangZhang 51 12/1/1990 12/1/1990
4 additional Officers and Directors records available in full report.

Business Names
Business Name
8049
Jilin Province Huinan Changlong Bio-Phar

General Information
Number of Employees: 848 (As of 12/31/2023)
Outstanding Shares: 560,250,000 (As of 12/31/2023)
Stock Exchange: HKG
Fax Number: +86 4358210005


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024